FOLR1 and ovarian cancer: Several studies, including ours have used microfluidic devices to capture EVs and quantify levels of proteins such as CD24, CA-125, EpCAM, EGFR, HER2 and/or FOLR1 from ovarian cancer patients’ plasma or ascites samples28-32.